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Summary
Introduction: The mortality rate of opioid users is 5 to 10 times greater than that of the general population, and the most 
common cause of death in that case is an overdose. When treated in a timely fashion with the opioid antagonist naloxone, 
an opioid overdose is rarely lethal. Unfortunately, many opioid overdoses occur in isolated, hidden, inaccessible locations. 
To circumvent this problem, the Villa Maraini Foundation in Rome has created a rescue team called ‘the Street Unit’ to 
provide basic life support and administer naloxone for the treatment of opioid overdose in urban environments. The aim of 
this paper is to review the cost-effectiveness of our Street Unit. Methods: We compared the cost of 90 overdose interven-
tions provided by the Street Unit with the cost of those provided by the Accident & Emergency departments of the Italian 
National Health System. Results: The Street Unit not only successfully treated all overdoses, but also provided a dramatic 
reduction in costs, ranging from €123,367.05 (best-case scenario) to €203,377.05 (worst-case scenario). Conclusions: 
This finding suggests that the treatment of opioid overdose in the street context offers a safe, cost-effective strategy for the 
reduction of opioid overdose-related mortality.
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1. Introduction
The most harmful consequence of opioid abuse 
is a potentially lethal overdose. The mortality rate of 
European opioid users has been estimated to be 5 to 
10 times greater than that of their peers of the same 
age and gender, and the most common cause of death 
in that case is an overdose [13, 17, 18]. It must, how-
ever, be pointed out that the actual number of deaths 
due to opioid overdose is not easy to estimate. In 
2014, according to the UNODC, there have been more 
than 200,000 drug-related deaths worldwide, and one 
third to one half of these deaths were attributed to 
opioid overdose. The European Drug Report by the 
European Monitoring Centre for Drugs and Drug Ad-
diction [14] estimates that opioid overdose accounts 
for about 2.5% of all deaths in Europeans aged 15-39 
(about 80% of such deaths were in males).
Estimating the trend over time for the inci-
dence of opioid overdose in Europe requires cau-
tion for a number of reasons, including systematic 
under-reporting in some countries and delays in the 
registration of cases. Countries with relatively robust 
reporting systems (e.g., Germany, Sweden, the UK) 
reported an increase in the number of overdoses in 
the past few years [14]. Another worrying trend is the 
increased number of overdoses due to opioids other 
than heroin. Methadone, buprenorphine, fentanyl 
(and its derivatives), and tramadol are now responsi-
ble for a substantial share of overdose deaths in some 
countries. 
Even more dramatic is the increase in the inci-
dence of opioid overdose in the last two decades in 
the USA, due to a steep increase in the abuse of both 
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heroin and prescription opioids [6]. Between 2000 
and 2014, opioid overdoses were responsible for 
about 28,000 deaths in the USA and heroin overdoses 
have more than tripled since 2010 [21]. 
Only a small proportion of first-time opioid 
overdoses result in the death of the user [9]. The ma-
jor reason for the relatively low mortality attributable 
to an opioid overdose is the widespread use of the 
opioid antagonist naloxone. Indeed, the administra-
tion of naloxone in cases of opioid overdose can be 
recognized as one of the most important life-saving 
interventions ever introduced in the Accident & 
Emergency (A&E) sector. In this clinical context, the 
treatment of the overdose is almost always successful. 
In contrast, the treatment of the overdose outside the 
hospital setting is still unsatisfactory in a great many 
cases [24]. Thus, a new approach has been promoted 
in the recent years, consisting in the training of non-
medical staff (i.e. opiate users and their peers) for the 
administration of naloxone outside the clinical con-
text. In this regard, in 2015, the EMCDDA published 
a systematic review of the effectiveness of take-home 
naloxone in a series of studies involving 2,912 opioid 
users at risk of overdose in 19 communities followed 
up for seven years. The review emphasized that edu-
cational and training interventions complemented by 
take-home naloxone lead to a fall in overdose-related 
mortality [14].
It must be added that heroin overdoses often oc-
cur in isolated, hidden, inaccessible locations, and 
the addict is often alone. Even when the addict is 
not alone, fatalities can occur in more than half of all 
cases, as the other addicts present on the scene are 
often unable to diagnose the event, or are themselves 
incapacitated by drug-taking, or are reluctant to seek 
help because they fear arrest [25, 8, 19]. In addition, 
naloxone is not always easily available for prompt use 
in cases of overdose. Based on data from the Villa 
Maraini Foundation (VMF, a non-profit organization 
affiliated to the Italian Red Cross with a 40-year ex-
perience in the treatment of substance abuse), in 90% 
of cases the substance is consumed at a short distance 
from the place where the purchase took place, usually 
in public areas such as city parks, gardens and streets. 
This circumstance lowers the chances of receiving 
prompt aid if an emergency occurs. 
In order to cope with this issue, VMF devel-
oped a Street Unit to provide assistance to opioid 
users directly in the settings of drug use. In order to 
optimize this approach, branches of the Street Unit 
were located in areas of Rome with a high prevalence 
of drug use, particularly of heroin. In addition to its 
main aim of providing first aid in case of overdose, 
the Street Unit also advises drug users on how to en-
rol in substance misuse services, distributes condoms 
and sterile syringes, and collects used syringes. These 
services play an important role in the National Health 
System in terms of cost-effectiveness. 
The costs of sending people to hospital for the 
treatment of drug overdoses in Italy are monitored 
by the Dipartimento per le Politiche Antidroga (De-
partment of Antidrug Policies), a special unit of the 
Ministry of Internal Affairs. Every year a special re-
port on Italian drug addiction is published for Parlia-
ment [7]. These costs can be estimated on the basis 
of the fees charged by the relevant Diagnosis-Related 
Group (DRG), which in the case of an overdose are 
DRG-454 and DRG-455 (see below). According to 
data obtained from the Ministry of Health, in 2016 
there were 44 cases of DRG-454 and 99 of DRG-455 
in the region of Latium. Despite possible issues with 
their reliability [7], these data were useful for calcu-
lating the cost-effectiveness of the VMF Street Unit.
2. Methods
2.1. The Street Unit and study context
The Street Unit is a rescue team comprising a 
psychologist, social workers (former drug users), Red 
Cross volunteers, and a physician. The social workers 
are trained to perform basic life support and admin-
ister naloxone. In their new capacity as social work-
ers, former addicts provide added value to the quality 
of team intervention, especially in the street context. 
They speak the same slang as drug users, are more 
trustworthy than professional staff, and have first-
hand experience of all aspects of drug-taking. Over 
the years, these social workers have played a crucial 
role in contacting drug users and enrolling them in the 
therapeutic programmes of the VMF. The Street Unit 
reaches the high-risk city areas every day by means 
of a camper van equipped with first aid and cardio-
pulmonary resuscitation instruments and kits for in-
tramuscular or intravenous naloxone administration. 
Among the areas at highest risk for the preva-
lence of drug consumption in Rome, there are the Tor 
Bella Monaca district on the outskirts of the city, and 
the areas surrounding “Roma Termini” railway sta-
tion located in the city centre. In this sense, the VMF 
Street Unit functions as a daily point of reference for 
drug users in these crucial areas. The service provided 
by the Street Unit functions as a reliable safeguard 
for the health of drug users for at least ten hours a 
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day. In addition to the fixed location provided by 
the camper, groups of two team members carry out 
onsite inspections of the entire area in order to iden-
tify, monitor and rescue any subjects who are alone 
when using substances. For each treated overdose, a 
Street Unit member collects data about the rescued 
subject, such as demographic data, conditions under 
which the overdose was taken, and current therapeu-
tic programmes.
2.2. Costs calculation
Hospital costs are easy to calculate because 
they can be derived from the reimbursement mecha-
nism adopted by the Italian National Health System 
(NHS), which, like most other European health sys-
tems, employs the DRG classification of hospital cas-
es [3]. Opioid overdoses are classified as DRG-454 or 
DRG-455 (with and without complications, respec-
tively) [16]. The cost for each admission is €1,704 for 
DRG-455 and €2,593 for DRG-454, regardless of the 
effective length of stay (up to a maximum of 21 days 
spent in hospital).
The calculation of the costs for the VMF Street 
Unit is more complex, as the service contract with 
the Regional Health Agency covers the entire activity 
of the Street Unit, not only the interventions imple-
mented in treating an overdose. The actual financial 
worth of the intervention should be calculated by tak-
ing into account the financial value of the human and 
material resources used, the savings in terms of health 
care, and the social impact of reducing the damage 
caused by opioid-related deaths. Additional factors 
that should be taken into consideration are the reduc-
tion of the harm caused to others, in terms of interper-
sonal relationships (e.g., family and friends) and the 
risk of spreading infective diseases (e.g., HIV, HCV, 
HBV). On the other hand, any estimate of these gains 
would inevitably be based on a series of a priori as-
sumptions on which there is no consensus. At present, 
the overall service provided by the VMF Street Unit 
includes (in addition to the treatment of street over-
doses): prevention, information, training in safety 
measures, an alert system, deterrence of smugglers/
pushers, control of the territory, providing first aid, 
along with other types of therapeutic intervention). 
The cost of the Street Unit is €83,125 for 180 days of 
service, equivalent to ten calendar months. The over-
dose interventions make up only a fraction of the total 
service. In estimating its overall financial value we 
used the following algorithm:
1. calculation of the cost of the human resourc-
es consists of
a) appraisal of the average time of inter-
vention (from the emergency call to the 
moment of leaving the patient) by the 
professional profile obtained through in-
terviewing the components of the team;
b) calculation of the hourly wage of each 
component based on the salary bill;
c) the total cost of the work done is equal to 
the sum of the hourly wage multiplied by 
the average time spent working weighted 
by the number of interventions carried 
out;
2. calculation of the cost of the materials and 
technical resources consists of 
d) the quote of the work time engaged cal-
culated with a) in the case of overdose 
events;
e) the difference between total budget and 
the correspondent cost of human resourc-
es;
f) the product of d) and e)
3. the financial appraisal of the quantity of 
VMF’s resources used for the project con-
sists of
g) the quote of the fund devoted to the street 
unit in the total budget;
h) the product of g) with the tangible assets 
and the intangible assets
4. the sum of 1, 2 and 3 provides the financial 
value of the service.
3. Results
It must be emphasized that the primary aim of 
VMF activity, consistently with its Red Cross affilia-
tion, is that of saving lives. Thus, given the extremely 
difficult and potentially dangerous circumstances 
under which the VMF Street Unit operates, and the 
constraints to be faced in terms of available staff, the 
collection of data giving details about its activity has 
had to take a back seat relative to the need to provide 
life-saving interventions in a timely manner.
Bearing those facts in mind, in the period Janu-
ary 2015-October 2016 an effort was made to collect 
data with the precise aim of assessing the efficacy of 
the service according to the criteria established by the 
Regional Health Council of the Region of Latium. 
The most important data thus collected are presented 
in Tables 1-3.
First of all, it is important to point out that (as 
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shown in Table 1) all 90 heroin overdoses were suc-
cessfully treated. Eighteen individuals were treated 
for more than 1 overdose occurring on different oc-
casions. Table 1 also provides basic information con-
cerning the demographics of the sample. Tables 2 and 
3 report the circumstances of the overdose, and the 
treatment programme in which the patients were then 
enrolled, respectively.
3.1. Cost-effectiveness of the VMF naloxone 
programme
Table 4 provides a synopsis of the criteria used 
for the analyses and Table 5 summarizes the compari-
son between the financial value of the 90 naloxone 
interventions provided by VMF Street Units and the 
cost of 90 hospital admissions for DRG-454 or DRG-
455. For this comparison two scenarios were used. In 
the best-case scenario all interventions were without 
complications (i.e. only DRG-455 was considered). 
In the worst-case scenario all interventions were with 
complications (i.e. only DRG-454 was considered). 
The savings for the NHS varied from a minimum of 
€123,367.05 (best-case scenario) to a maximum of 
€203,377.05 (worst-case scenario).
4. Discussion
The VMF Street Unit provides an alternative to 
sending people to hospital for the treatment of hero-
in overdoses in the street context. Thus, it is vital to 
compare the cost-effectiveness of the two options. 
There are at least two possible approaches to 
the evaluation of the cost-effectiveness of therapeu-
Table 1. Demographics 
Number of overdoses 90
Number of individuals 72
Sex
 Female (%)
 Male (%)
10 (13.9%)
62 (86.1%)
Age
Years (mean±SEM) 39.8±1.06
Education (MD=38)
 5-7 years (%)
 8-12 (%)
 ≥ 13 (%)
1 (2.9%)
22 (64.7%)
11 (32.4%)
Marital status (MD=6)
 Singles (%)
 Married (%)
 Partner (%)
 Separated/divorced (%)
 Widowed (%)
43 (65.2%)
6 (9.1%)
7 (10.6%)
9 (13.6%)
1 (1.5%)
Nationality
 Italians (%)
 Foreigners (%)
70 (97.2%)
2 (2.8%)
Age at first heroin use (MD=9)
Years (mean±SEM) 19.8±0.69
Years of heroin use (MD=5)
 > 10 (%)
 6-10 (%)
 1-5 (%)
 < 1 (%)
48 (71.6%)
11 (16.4%)
 7 (10.4%)
 1 (1.5%)
Frequency of heroin use (MD=6)
 > 1/day (%)
 1/day (%)
 > 1-6/week (%)
 < 1/week (%)
26 (39.4%)
11 (16.7%)
16 (24.2%)
13 (19.7%)
Data are expressed as absolute or relative (%) frequencies or 
as means±SEMs. 
MD = Missing Data
Table 2. Circumstances of the overdose
Physical setting (MD=2)
 Street (%)
 Park (%)
 Other (%)
66 (75.0%)
22 (22.7%)
 2 (2.3%)
Social setting
 Alone (%)
 In company (%)
26 (28.9%)
64 (71.1%)
Increase in dose (MD=6)
 Yes (%)
 No (%)
7 (8.3%)
77 (91.7%)
Change in dealer (MD=10)
 Yes (%)
 No (%)
6 (7.5%)
74 (92.5%)
Withdrawal syndrome (MD=8)
 Yes (%)
 No (%)
5 (6.1%)
77 (93.9%)
Recent release from prison (MD=10) 
 < 3 days (%)
 3-7 days (%)
 > 7 days (%)
 None (%)
2 (2.5%)
 0 (0.0%)
13 (16.25%)
65 (81.25%)
Poly-drug use (MD = 6)
 Benzodiazepine (%)
 Cocaine (%)
 Alcohol (%)
 Street Methadone (%)
 Cocaine + Benzodiazepine (%)
 Cocaine + Alcohol (%)
 Alcohol + Benzodiazepine (%)
 Amphetamine + Benzodiazepine (%)
 None (%)
19 (22.6%)
 9 (10.7%)
 4 (4.7%)
 3 (3.6%)
 2 (2.4%)
 2 (2.4%)
 1 (1.2%)
 1 (1.2%)
42 (50.0%)
Data are expressed as absolute or relative (%) frequencies. 
MD = Missing Data
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tic programmes. One approach follows the theory of 
‘Welfarism’ according to which, “the goodness of 
states of affairs depends ultimately only on the per-
sonal utilities in the respective states” [22]. Welfarism 
is based on the application of the marginalist theory 
of value to health-related phenomena, and requires a 
utilitarian function that measures the advantage of an 
additional monetary unit devoted to well-being com-
pared with other targets. In our case, given that the 
counterfactual scenario of not administering naloxone 
is the death of the patient, we should calculate the 
utility function of saving the patient’s life [2, 11, 10, 
15]. On the practical plane, as a matter of principle 
we reject such a calculation because no market price 
can be sensibly quoted for human life.
The alternative ‘non-welfarist’ approach is cur-
rently the prevailing approach to the calculation of 
cost-effectiveness in the health sector [15]. This ap-
proach is based on a microeconomic analysis that 
takes into account the impossibility for the private 
sector to guarantee efficient solutions without gov-
ernment intervention. The major difference with the 
welfarist approach is the maximization of aggrega-
tion utilities for a set of objectives defined outside 
a state of market equilibrium. Thus, the utility func-
tion is replaced by functions that measure the qual-
ity of health. The most frequently used methodology 
is based on Quality-Adjusted Life Years (QALY), 
which calculates the years of life saved when death is 
avoided, by using quality weighting [15].
Following this approach, Coffin and Sullivan 
[5, 4] analysed the cost-effectiveness of distributing 
naloxone to addicts at risk of overdose, and found 
that in terms of QALY it was superior to most health 
interventions currently supported by governments. 
This “first attempt to apply the tools of mathematical 
modelling to opioid overdose” marks a turning point 
for the evaluation of the cost-effectiveness of using 
naloxone for the treatment of an opioid overdose. 
Despite this achievement, the methodology used by 
Coffin and Sullivan must be criticized because of 
three important limitations: i) it employed 27 param-
eters based on other studies and a number of assump-
tions; ii) the procedure does not follow the rules of 
Table 3. Current therapeutic programme of the patients. 
Structure/organization (MD=4)
 SerT (%)
 Therapeutic community (%)
 None (%)
30 (34.9%)
5 (5.8%)
51 (59.3%)
Therapeutic program (MD=7)
 Methadone decreasing doses
 Methadone maintenance
 Psychosocial
11 (39.3%)
14 (50.0%)
3 (10.7%)
Methadone dose (MD=12)
 Maintenance treatment (mean + SEM) 
 Decreasing doses treatment
29.2 ± 
6.5123
20.5 ± 
4.1130
Take-home naloxone (MD=16)
 Yes (%)
 No (%)
16 (21.6%)
58 (78.4%)
Data are expressed as absolute or relative (%) frequencies or 
as means±SEMs. MD = Missing Data
Table 4. The components of financial cost incurred by 
the Villa Maraini Foundation (VMF) Street Unit for 90 
overdoses
Item Value in euro
1. Labour cost 14,774.40
2. Medical supplies and technical re-
sources cost 2,101.57
3. VMF’s resources used cost 13,116.98
Table 5. Comparison between financial cost of National Health System (NHS) and Villa Maraini Foundation (VMF) 
for 90 interventions.
Item Number of overdoses Financial cost of the NHS
Financial cost of 
VMF
Saving 
(Deficit)
Worst-case scenario (only 
DRG 454) 90 233,370 29,992.95 203,377.05
Best-case scenario (only 
DRG 455) 90 153,360 29,992.95 123,367.05
DRG = Diagnosis-Related Group
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Randomized Clinical Trials; iii) individual (set) and 
environmental (setting) factors were ignored. Fur-
thermore, the unique features of opioid addiction 
are not adequately reflected by Coffin and Sullivan’s 
mathematical model based on a Markov chain [1, 23], 
which is dependent on the last observation and not on 
the historical series of observations, and on ergodicity 
(that is, on a behaviour that remains stable over time).
To overcome these limitations in the present 
study we have used a methodology derived from the 
concept of economic evaluation, “the comparative 
analysis of alternative courses of action in terms of 
both their costs and consequences” [12]. One pos-
sibility is to calculate the costs of a naloxone inter-
vention (the opportunity cost) versus the gains (the 
benefit): this is based on a cost function coherent with 
the theory of marginal analysis [11, 20]. However, 
the public health authority and public opinion both 
need a measure of the allocation of health resources 
in terms of its ability to improve the quality of life 
at three levels: individual, social, and medical. The 
first level concerns the would-be patient; the second 
concerns the general health status of the community; 
the third level concerns the epidemiological status of 
the population. In the present case, the methodology 
that is most appropriate for the achievement of these 
goals is that of comparing the cost of the interven-
tion implemented by the VMF Street Unit with the fee 
charged by the A&E department of a hospital.
5. Conclusions
Too many addicts still die because of an over-
dose taken on a street. In most cases these deaths 
could be prevented by the timely administration of 
naloxone. The Villa Maraini Foundation has played 
a pioneering role in arranging for former addicts to 
be trained in diagnosing overdoses and then giving 
treatment with injectable naloxone in difficult street 
contexts. The saving of these lives not only fulfils 
the institutional aims of an organization affiliated to 
the International Movement of Red Cross and Red 
Crescent, it also meets more concrete societal needs. 
Indeed, the data reported here clearly show the cost-
effectiveness of the naloxone programmes run by the 
VMF Street Unit with respect to a comparable service 
provided by the Italian National Health Care System. 
It is important to emphasize the range of services pro-
vided by the VFM Street Units, including first aid to 
be given to dropouts and people with abuse problems, 
prevention, providing information, fully supporting 
the fight against drug smugglers and helping in the 
struggle to win territorial control against all forms of 
crime. These services are not included in the financial 
cost sustained by the NHS expressed in DRG, as the 
calculation of these costs lies outside the scope of this 
paper.
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